FDA Advisory Committees on the Brink: More Meetings, Fewer Members

A year ago, Congress sent FDA two very clear, somewhat contradictory messages: Hold more advisory committee meetings, but without the use of many expert panelists used in the past. The result is a system that is stretched to the limits.

These days, everyone is being asked to do more with less.

The Food & Drug Administration is no exception. Congress is asking FDA hold more advisory committee reviews for new product...

More from Archive

More from Pink Sheet